Legal Opinion

In Re Regulus Therapeutics Inc. Securities Litigation

District Court, S.D. California

Decided September 5, 2019No. 3:17-cv-00182Unknown

1Opinion

1 2 3 4 5 6 7 8 9 UNITED STATES DISTRICT COURT 10 SOUTHERN DISTRICT OF CALIFORNIA 11 12 IN RE REGULUS Case No.: 3:17-cv-0182-BTM-RBB THERAPEUTICS INC. 13 SECURITIES LITIGATION ORDER GRANTING 14 DEFENDANTS’ MOTION TO DISMISS AND GRANTING 15 PLAINTIFFS LEAVE TO AMEND 16 [ECF No. 22] 17 18 19 20 This is a putative securities class action filed on behalf of all purchasers of 21 common shares of Regulus Therapeutics, Inc. (“Regulus”) between February 17, 22 2016 and June 12, 2017, inclusive (the “Class Period”). Plaintiffs allege that 23 Defendants Regulus, Joseph P. Hagan, Paul C. Grint, M.D.,…

2Cases cited25 opinions

  1. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  2. Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
  3. Matrixx Initiatives, Inc. v. SiracusanoSupreme Court of the United States · 2011
  4. Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc.Supreme Court of the United States · 2008
  5. Martin v. Hunter's LesseeSupreme Court of the United States · 1816

20 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API